Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EoL-1, a human eosinophilic cell line.

M Mayumi1

  • 1Department of Pediatrics, Kyoto University Hospital, Japan.

Leukemia & Lymphoma
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

EoL-1 cells, a human eosinophilic leukemia cell line, mimic myeloblasts but can differentiate into eosinophils. This cell line is valuable for studying eosinophil properties and leukemia cell differentiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative unspun-urine microscopy as a quick, reliable examination for bacteriuria.

Scandinavian journal of clinical and laboratory investigation·2005
Same author

Association between interleukin-18 gene polymorphism 105A/C and asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2003
Same author

Reversible diffusion-weighted MR findings of Salmonella enteritidis-associated encephalopathy.

European neurology·2003
Same author

Removal of mutagen precursor from wastewater by activated sludge and oxidation treatment.

Water science and technology : a journal of the International Association on Water Pollution Research·2003
Same author

Diagnosis of fructose-1,6-bisphosphatase deficiency using cultured lymphocyte fraction: a secure and noninvasive alternative to liver biopsy.

Journal of inherited metabolic disease·2002
Same author

Hepatitis C virus genotypes in the Islamic Republic of Iran: a preliminary study.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2001
Same journal

Glofitamab for the treatment of relapsed/refractory hairy cell leukemia: a case report.

Leukemia & lymphoma·2026
Same journal

Pre- and post-transplant serum albumin levels and outcomes after allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia.

Leukemia & lymphoma·2026
Same journal

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

Leukemia & lymphoma·2026
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
See all related articles

Area of Science:

  • Hematology
  • Cell Biology
  • Cancer Research

Background:

  • Eosinophilic leukemia is a rare hematological malignancy.
  • Understanding leukemic cell differentiation is crucial for developing targeted therapies.
  • A suitable in vitro model is needed to study eosinophil biology and related leukemias.

Purpose of the Study:

  • To characterize the EoL-1 cell line, a novel human eosinophilic leukemia model.
  • To evaluate the differentiation potential of EoL-1 cells into eosinophils.
  • To establish EoL-1 cells as a model for studying eosinophil function and leukemia.

Main Methods:

  • Culturing and characterizing the EoL-1 cell line.
  • Inducing differentiation of EoL-1 cells using various stimuli.

Related Experiment Videos

  • Analyzing phenotypic and functional changes during differentiation.
  • Main Results:

    • EoL-1 cells exhibit myeloblast-like features under normal conditions.
    • Stimulation induces phenotypic and functional differentiation into eosinophils.
    • EoL-1 cells demonstrate potential as a model for eosinophilic leukemia.

    Conclusions:

    • EoL-1 cells serve as a valuable model for human eosinophilic leukemia research.
    • The cell line facilitates the study of leukemic cell differentiation and eosinophil properties.
    • EoL-1 cells offer insights into human eosinophil function and regulation.